New insights into the role of stromal cell-derived factor 1 (SDF-1/CXCL12) in the pathophysiology of multiple sclerosis

Journal of Neuroimmunology

Volumn 290, Issue , 2016, Pages 70-75

  Khorramdelazad, Hossein ^a   Bagheri, Vahid ^a   Hassanshahi, Gholamhossein ^a   Zeinali, Masoud ^b   Vakilian, Alireza ^a  

^a RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CXC chemokine; CXCL12; MS; Multiple sclerosis; SDF 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, HUMAN; CYTOKINE;

CEREBROSPINAL FLUID ANALYSIS; GLIA CELL; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE MIGRATION; LYMPHOCYTE; MONOCYTE; MULTIPLE SCLEROSIS; NERVE CELL; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; CHEMOKINE CXCL12; CYTOKINES; HUMANS; LYMPHOCYTES; MONOCYTES; MULTIPLE SCLEROSIS;

EID: 84955062791     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.11.021     Document Type: Review

References (90)

1. Al-Aoukaty A., Schall T., Maghazachi A. Differential coupling of CC chemokine receptors to multiple heterotrimeric G proteins in human interleukin-2-activated natural killer cells. Blood 1996, 87:4255-4260.
2. Ambrosini E., Remoli M.E., Giacomini E., Rosicarelli B., Serafini B., Lande R., et al. Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 2005, 64:706-715.
3. Aminzadeh F., Ghorashi Z., Nabati S., Ghasemshirazi M., Arababadi M.K., Shamsizadeh A., et al. Differential expression of CXC chemokines CXCL10 and CXCL12 in term and pre-term neonates and their mothers. Am. J. Reprod. Immunol. 2012, 68:338-344.
4. Ara T., Tokoyoda K., Okamoto R., Koni P.A., Nagasawa T. The role of CXCL12 in the organ-specific process of artery formation. Blood 2005, 105:3155-3161.
5. Aranami T., Yamamura T. Th17 cells and autoimmune encephalomyelitis (EAE/MS). Allergol. Int. 2008, 57:115-120.
6. Azin H., Vazirinejad R., Ahmadabadi B.N., Khorramdelazad H., Zarandi E.R., Arababadi M.K., et al. The SDF-1 3' A genetic variation of the chemokine SDF-1α (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients. J. Mol. Neurosci. 2012, 47:431-436.
7. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 1997, 15:675-705.
8. Bajetto A., Bonavia R., Barbero S., Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J. Neurochem. 2002, 82:1311-1329.
9. Banisadr G., Frederick T.J., Freitag C., Ren D., Jung H., Miller S.D., et al. The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiol. Dis. 2011, 44:19-27.
10. Banisadr G., Podojil J.R., Miller S.D., Miller R.J. Pattern of CXCR7 gene expression in mouse brain under normal and inflammatory conditions. J. Neuroimmune Pharmacol. 2015, 1-10.
11. Biber K., Zuurman M.W., Dijkstra I.M., Boddeke H.W. Chemokines in the brain: neuroimmunology and beyond. Curr. Opin. Pharmacol. 2002, 2:63-68.
12. Bielecki B., Jatczak-Pawlik I., Wolinski P., Bednarek A., Glabinski A. Central nervous system and peripheral expression of CCL19, CCL21 and their receptor CCR7 in experimental model of multiple sclerosis. Arch. Immunol. Ther. Exp. 2015, 1-10.
13. Boutet A., Salim H., Leclerc P., Tardieu M. Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons. Neurosci. Lett. 2001, 311:105-108.
14. Burek M., Haghikia A., Gold R., Roewer N., Chan A. Differential cytokine release from brain microvascular endothelial cells treated with dexamethasone and multiple sclerosis patient sera. J. Steroids Horm. Sci. 2014, 5:2.
15. Busillo J.M., Benovic J.L. Regulation of CXCR4 signaling. Biochim. Biophys. Acta Biomembr. 2007, 1768:952-963.
16. Busillo J.M., Armando S., Sengupta R., Meucci O., Bouvier M., Benovic J.L. Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling. J. Biol. Chem. 2010, 285:7805-7817.
17. Calderon T.M., Eugenin E.A., Lopez L., Kumar S.S., Hesselgesser J., Raine C.S., et al. A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 2006, 177:27-39.
18. Cartier L., Hartley O., Dubois-Dauphin M., Krause K.-H. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res. Rev. 2005, 48:16-42.
19. Casoni F., Hutchins B.I., Donohue D., Fornaro M., Condie B.G., Wray S. SDF and GABA interact to regulate axophilic migration of GnRH neurons. J. Cell Sci. 2012, 125:5015-5025.
20. Cheng W., Chen G. Chemokines and chemokine receptors in multiple sclerosis. Mediat. Inflamm. 2014, 2014.
21. Cohen M.E., Fainstein N., Lavon I., Ben-Hur T. Signaling through three chemokine receptors triggers the migration of transplanted neural precursor cells in a model of multiple sclerosis. Stem Cell Res. 2014, 13:227-239.
22. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:11064-11069.
23. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., et al. Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 1997, 16:6996-7007.
24. Cruz-Orengo L., Chen Y.-J., Kim J.H., Dorsey D., Song S.-K., Klein R.S. CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity. J. Neuroinflammation 2011, 8.
25. Cruz-Orengo L., Holman D.W., Dorsey D., Zhou L., Zhang P., Wright M., et al. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 2011, 208:327-339.
26. Cui L., Qu H., Xiao T., Zhao M., Jolkkonen J., Zhao C. Stromal cell-derived factor-1 and its receptor CXCR4 in adult neurogenesis after cerebral ischemia. Restor. Neurol. Neurosci. 2012, 31:239-251.
27. Décaillot F.M., Kazmi M.A., Lin Y., Ray-Saha S., Sakmar T.P., Sachdev P. CXCR7/CXCR4 heterodimer constitutively recruits β-arrestin to enhance cell migration. J. Biol. Chem. 2011, 286:32188-32197.
28. Dendrou C.A., Fugger L., Friese M.A. Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 2015.
29. Derakhshan R., Arababadi M.K., Ahmadi Z., Karimabad M.N., Salehabadi V.A., Abedinzadeh M., et al. Increased circulating levels of SDF-1 (CXCL12) in type 2 diabetic patients are correlated to disease state but are unrelated to polymorphism of the SDF-1β gene in the Iranian population. Inflammation 2012, 35:900-904.
30. Dobson R., Giovannoni G. Autoimmune disease in people with multiple sclerosis and their relatives: a systematic review and meta-analysis. J. Neurol. 2013, 260:1272-1285.
31. Duda D.G., Kozin S.V., Kirkpatrick N.D., Xu L., Fukumura D., Jain R.K. CXCL12 (SDF1α)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?. Clin. Cancer Res. 2011, 17:2074-2080.
32. Edwards K.R., Goyal J., Plavina T., Czerkowicz J., Goelz S., Ranger A., et al. Feasibility of the use of combinatorial chemokine arrays to study blood and CSF in. multiple sclerosis 2013.
33. Fan X., Lin C., Han J., Jiang X., Zhu J., Jin T. Follicular helper CD4 T cells in human neuroautoimmune diseases and their animal models. Mediat. Inflamm. 2015, 501:638968.
34. Fernandis A.Z., Prasad A., Band H., Klösel R., Ganju R.K. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells. Oncogene 2004, 23:157-167.
35. Giunti D., Borsellino G., Benelli R., Marchese M., Capello E., Valle M.T., et al. Phenotypic and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J. Leukoc. Biol. 2003, 73:584-590.
36. Guyon A. CXCL12 chemokine and its receptors as major players in the interactions between immune and nervous systems. Front. Cell. Neurosci. 2014, 8.
37. Hassanshahi G., Amin M., Shunmugavel A., Vazirinejad R., Vakilian A., Sanji M., et al. Temporal expression profile of CXC chemokines in serum of patients with spinal cord injury. Neurochem. Int. 2013, 63:363-367.
38. Hassanshahi G., Jafarzadeh A., Ghorashi Z., Sheikholeslami N.Z., Dickson A.J. Expression of IP-10 chemokine is regulated by pro-inflammatory cytokines in cultured hepatocytes. Iran. J. Allergy Asthma Immunol. 2007, 6:115-122.
39. Jadidi-Niaragh F., Mirshafiey A. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand. J. Immunol. 2011, 74:1-13.
40. Jiang Y., Salafranca M.N., Adhikari S., Xia Y., Feng L., Sonntag M.K., et al. Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J. Neuroimmunol. 1998, 86:1-12.
41. Khan M.Z., Brandimarti R., Shimizu S., Nicolai J., Crowe E., Meucci O. The chemokine CXCL12 promotes survival of postmitotic neurons by regulating Rb protein. Cell Death Differ. 2008, 15:1663-1672.
42. Kleinschek M.A., Owyang A.M., Joyce-Shaikh B., Langrish C.L., Chen Y., Gorman D.M., et al. IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 2007, 204:161-170.
43. Kohler R.E., Comerford I., Townley S., Haylock-Jacobs S., Clark-Lewis I., McColl S.R. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Brain Pathol. 2008, 18:504-516.
44. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisäkk P., Ransohoff R.M., et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129:200-211.
45. Kucia M., Jankowski K., Reca R., Wysoczynski M., Bandura L., Allendorf D.J., et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J. Mol. Histol. 2004, 35:233-245.
46. Lee P.W., Yang Y., Racke M.K., Lovett-Racke A.E. Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: implications for multiple sclerosis. Brain Behav. Immun. 2015, 46:44-49.
47. Li M., Ransohoff R.M. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 2008, 84:116-131.
48. Link D.C. Regulation of hematopoiesis by CXCL12/CXCR4 signaling. Targeted Therapy of Acute Myeloid Leukemia 2015, 593-605. Springer.
49. Lopez C., Comabella M., Tintore M., Sastre-Garriga J., Montalban X. Variations in chemokine receptor and cytokine expression during pregnancy in multiple sclerosis patients. Mult. Scler. 2006, 12:421-427.
50. Malik M., Chen Y.-Y., Kienzle M.F., Tomkowicz B.E., Collman R.G., Ptasznik A. Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1α through Lyn kinase. J. Immunol. 2008, 181:4632-4637.
51. McCandless E.E., Piccio L., Woerner B.M., Schmidt R.E., Rubin J.B., Cross A.H., et al. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am. J. Pathol. 2008, 172:799-808.
52. McCandless E.E., Wang Q., Woerner B.M., Harper J.M., Klein R.S. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 2006, 177:8053-8064.
53. Memi F., Abe P., Cariboni A., MacKay F., Parnavelas J.G., Stumm R. CXC chemokine receptor 7 (CXCR7) affects the migration of GnRH neurons by regulating CXCL12 availability. J. Neurosci. 2013, 33:17527-17537.
54. Moll N.M., Cossoy M.B., Fisher E., Staugaitis S.M., Tucky B.H., Rietsch A.M., et al. Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis. Arch. Neurol. 2009, 66:44-53.
55. Momcilović M., Mostarica-Stojković M., Miljković D. CXCL12 in control of neuroinflammation. Immunol. Res. 2012, 52:53-63.
56. Nagasawa T. CXC chemokine ligand 12 (CXCL12) and its receptor CXCR4. J. Mol. Med. 2014, 92:433-439.
57. Oh S.B., Endoh T., Simen A.A., Ren D., Miller R.J. Regulation of calcium currents by chemokines and their receptors. J. Neuroimmunol. 2002, 123:66-75.
58. O'Loughlin E. The Experience of Transitioning from Relapsing Remitting to Secondary Progressive Multiple Sclerosis 2015.
59. Ostadebrahimi H., Jamali Z., Nazari M., Bahri M., Farahmandnia Z., Khandany B.K., et al. CXC chemokines CXCL1, CXCL9, CXCL10 and CXCL12 are variably expressed in patients with sickle cell disease and carriers: are they predictive tools for disease complications?. Clin. Lab. 2013, 60:99-104.
60. Pachner A.R., Li L., Gilli F. Chemokine biomarkers in central nervous system tissue and cerebrospinal fluid in the Theiler's virus model mirror those in multiple sclerosis. Cytokine 2015.
61. Patrussi L., Baldari C.T. The CXCL12/CXCR4 axis as a therapeutic target in cancer and HIV-1 infection. Curr. Med. Chem. 2011, 18:497-512.
62. Pierson E. B Cells Promote Inflammatory T Cell Responses During the Initiation of Central Nervous System Autoimmune Disease 2013.
63. Poggi A., Catellani S., Fenoglio D., Borsellino G., Battistini L., Zocchi M.R. Adhesion molecules and kinases involved in γ δ T cells migratory pathways: implications for viral and autoimmune diseases. Curr. Med. Chem. 2007, 14:3166-3170.
64. Pujol F., Kitabgi P., Boudin H. The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J. Cell Sci. 2005, 118:1071-1080.
65. Rajagopal S., Kim J., Ahn S., Craig S., Lam C.M., Gerard N.P., et al. β-arrestin-but not G protein-mediated signaling by the "decoy" receptor CXCR7. Proc. Natl. Acad. Sci. 2010, 107:628-632.
66. Rao P., Segal B.M. Experimental autoimmune encephalomyelitis. Autoimmunity 2012, 363-380. Springer.
67. Ratajczak M.Z., Serwin K., Schneider G. Innate immunity derived factors as external modulators of the CXCL12-CXCR4 axis and their role in stem cell homing and mobilization. Theranostics 2013, 3:3.
68. Rot A., von Andrian U.H. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu. Rev. Immunol. 2004, 22:891-928.
69. Serrano-Pertierra E., Blanco-Gelaz M.A., Oliva-Nacarino P., Martínez-Camblor P., Villafani J., López-Larrea C., et al. Increased natural killer cell chemotaxis to CXCL12 in patients with multiple sclerosis. J. Neuroimmunol. 2015, 282:39-44.
70. Shirozu M., Nakano T., Inazawa J., Tashiro K., Tada H., Shinohara T., et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995, 28:495-500.
71. Steinman L. The discovery of natalizumab, a potent therapeutic for multiple sclerosis. J. Cell Biol. 2012, 199:413-416.
72. Stumm R., Höllt V. CXC chemokine receptor 4 regulates neuronal migration and axonal pathfinding in the developing nervous system: implications for neuronal regeneration in the adult brain. J. Mol. Endocrinol. 2007, 38:377-382.
73. Stys P.K., Zamponi G.W., van Minnen J., Geurts J.J. Will the real multiple sclerosis please stand up?. Nat. Rev. Neurosci. 2012, 13:507-514.
74. Takeshita Y., Ransohoff R.M. Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models. Immunol. Rev. 2012, 248:228-239.
75. Tashiro K., Tada H., Heilker R., Shirozu M., Nakano T., Honjo T. Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 1993, 261:600-603.
76. Thelen M., Thelen S. CXCR7, CXCR4 and CXCL12: an eccentric trio?. J. Neuroimmunol. 2008, 198:9-13.
77. Timotijević G., Stojković M.M., Miljković D. CXCL12: role in neuroinflammation. Int. J. Biochem. Cell Biol. 2012, 44:838-841.
78. Trapp B.D., Nave K.-A. Multiple sclerosis: an immune or neurodegenerative disorder?. Annu. Rev. Neurosci. 2008, 31:247-269.
79. Tse H.Y., Skundric D.S., Cruikshank W.W., Montgomery P.C., Lisak R.P. Immunopathology of CD4+ T Cell-Mediated Autoimmune Responses to Central Nervous System Antigens: Role of IL-16 2013.
80. Turbic A., Leong S.Y., Turnley A.M. Chemokines and inflammatory mediators interact to regulate adult murine neural precursor cell proliferation, survival and differentiation. PLoS ONE 2011, 6:e25406.
81. Vallon M., Chang J., Zhang H., Kuo C.J. Developmental and pathological angiogenesis in the central nervous system. Cell. Mol. Life Sci. 2014, 71:3489-3506.
82. Vazirinejad R., Ahmadi Z., Kazemi Arababadi M., Hassanshahi G., Kennedy D. The biological functions, structure and sources of CXCL10 and its outstanding part in the pathophysiology of multiple sclerosis. Neuroimmunomodulation 2014, 21:322-330.
83. Vila-Coro A.J., Rodríguez-frade J.M., De Ana A.M., Moreno-Ortíz M.C., Martínez -A C., Mellado M. The chemokine SDF-1α triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 1999, 13:1699-1710.
84. Westmoreland S., Alvarez X., Aye P., Wilson M., Williams K., Lackner A. Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J. Neuroimmunol. 2002, 122:146-158.
85. Wostradowski T., Gudi V., Lindquist J., Lindquist S., Stangel M. Interaction of interferon beta-1b and CXCR4 on T cells in multiple sclerosis. J. Neuroimmunol. 2014, 275:212.
86. Würth R., Bajetto A., Harrison J.K., Barbieri F., Florio T. CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front. Cell. Neurosci. 2014, 8.
87. Yang S., Edman L.C., Sánchez-Alcañiz J.A., Fritz N., Bonilla S., Hecht J., et al. Cxcl12/Cxcr4 signaling controls the migration and process orientation of A9-A10 dopaminergic neurons. Development 2013, 140:4554-4564.
88. Zabel B.A., Wang Y., Lewén S., Berahovich R.D., Penfold M.E., Zhang P., et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J. Immunol. 2009, 183:3204-3211.
89. Zhang M., Song A., Lai S., Qiu L., Huang Y., Chen Q., et al. Applications of stripe assay in the study of CXCL12-mediated neural progenitor cell migration and polarization. Biomaterials 2015.
90. Zhu Y., Murakami F. Chemokine CXCL12 and its receptors in the developing central nervous system: emerging themes and future perspectives. Dev. Neurobiol. 2012, 72:1349-1362.